These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 33365027)

  • 21. Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility.
    Wang X; Huang K; Jiang H; Hua L; Yu W; Ding D; Wang K; Li X; Zou Z; Jin M; Xu S
    Virol Sin; 2020 Dec; 35(6):793-802. PubMed ID: 33156486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19.
    Bonaventura A; Vecchié A; Dagna L; Martinod K; Dixon DL; Van Tassell BW; Dentali F; Montecucco F; Massberg S; Levi M; Abbate A
    Nat Rev Immunol; 2021 May; 21(5):319-329. PubMed ID: 33824483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children.
    Neeland MR; Bannister S; Clifford V; Dohle K; Mulholland K; Sutton P; Curtis N; Steer AC; Burgner DP; Crawford NW; Tosif S; Saffery R
    Nat Commun; 2021 Feb; 12(1):1084. PubMed ID: 33597531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 and Peripheral Smear Chat.
    Alabbadi AM; Yassin DF; Mansour AT; Al-Abbadi MA
    Acta Cytol; 2021; 65(1):1-3. PubMed ID: 32799199
    [No Abstract]   [Full Text] [Related]  

  • 25. [Involvement of the complement cascade in severe forms of COVID-19].
    Chouaki Benmansour N; Carvelli J; Vivier É
    Med Sci (Paris); 2021 Apr; 37(4):333-341. PubMed ID: 33835019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T Cell Memory: Understanding COVID-19.
    Jarjour NN; Masopust D; Jameson SC
    Immunity; 2021 Jan; 54(1):14-18. PubMed ID: 33406391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repurposing CD8
    Gujar S; Pol JG; Kim Y; Kroemer G
    Oncoimmunology; 2020 Jul; 9(1):1794424. PubMed ID: 32923158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A promiscuous interaction of SARS-CoV-2 with bacterial products.
    Carissimo G; Ng LFP
    J Mol Cell Biol; 2020 Nov; 12(12):914-915. PubMed ID: 33326034
    [No Abstract]   [Full Text] [Related]  

  • 29. [The neurology of COVID-19].
    Cuevas-García C; Calderón-Vallejo A; Berrón-Ruiz L
    Rev Alerg Mex; 2020; 67(4):338-349. PubMed ID: 33631902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID, Biologics, and Psoriasis Therapy.
    Elston DM
    J Am Acad Dermatol; 2020 Dec; 83(6):1577-1578. PubMed ID: 33051006
    [No Abstract]   [Full Text] [Related]  

  • 31. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective Effects of Lactoferrin against SARS-CoV-2 Infection In Vitro.
    Salaris C; Scarpa M; Elli M; Bertolini A; Guglielmetti S; Pregliasco F; Blandizzi C; Brun P; Castagliuolo I
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33498631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial cell, myeloid, and adaptive immune responses in SARS-CoV-2 infection.
    Degauque N; Haziot A; Brouard S; Mooney N
    FASEB J; 2021 May; 35(5):e21577. PubMed ID: 33831263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
    Bouayad A
    Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
    Costela-Ruiz VJ; Illescas-Montes R; Puerta-Puerta JM; Ruiz C; Melguizo-Rodríguez L
    Cytokine Growth Factor Rev; 2020 Aug; 54():62-75. PubMed ID: 32513566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.
    Beacon TH; Su RC; Lakowski TM; Delcuve GP; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2331-2354. PubMed ID: 32936531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute peripheral arterial thrombosis in COVID-19. Role of endothelial inflammation.
    Gonzalez Cañas E; Gimenez Gaibar A; Rodriguez Lorenzo L; Castro Rios JG; Martinez Toiran A; Bella Cueto MR; Bella Burgos B; Espasa Soley M
    Br J Surg; 2020 Sep; 107(10):e444-e445. PubMed ID: 32757386
    [No Abstract]   [Full Text] [Related]  

  • 38. Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19.
    Paolini A; Borella R; De Biasi S; Neroni A; Mattioli M; Lo Tartaro D; Simonini C; Franceschini L; Cicco G; Piparo AM; Cossarizza A; Gibellini L
    Cells; 2021 Jun; 10(7):. PubMed ID: 34201847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-type lectins and extracellular vesicles in virus-induced NETosis.
    Sung PS; Hsieh SL
    J Biomed Sci; 2021 Jun; 28(1):46. PubMed ID: 34116654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oromucosal immunomodulation as clinical spectrum mitigating factor in SARS-CoV-2 infection.
    Rodríguez-Argente F; Alba-Domínguez M; Ortiz-Muñoz E; Ortega-González Á
    Scand J Immunol; 2021 Jan; 93(1):e12972. PubMed ID: 32892403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.